We found a higher CT%, as well as serum levels of CRP, neutralizing antibodies to the SARS-CoV-2 Omicron strain, and total anti-SARS-CoV-2 antibodies in moderate compared to mild forms of COVID-19. The gene discussed is CRP; the disease is COVID-19.